U.S. markets close in 19 minutes

Cannabis Sativa, Inc. (CBDS)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.0100+0.2110 (+26.41%)
As of 3:26PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.7990
Open0.8200
BidN/A x N/A
AskN/A x N/A
Day's Range0.7712 - 1.0800
52 Week Range0.3200 - 1.5300
Volume690,876
Avg. Volume189,343
Market Cap27.419M
Beta (5Y Monthly)3.30
PE Ratio (TTM)N/A
EPS (TTM)-0.1570
Earnings DateJun 29, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Cannabis Sativa Reports $459,786 Revenue in Q3, Revenues for Nine Months ended September 30 up 137% over first 3 Quarters of 2019
    GlobeNewswire

    Cannabis Sativa Reports $459,786 Revenue in Q3, Revenues for Nine Months ended September 30 up 137% over first 3 Quarters of 2019

    Mesquite, Nov. 17, 2020 (GLOBE NEWSWIRE) -- MESQUITE, NV / November 17, 2020 / Cannabis Sativa, Inc. (OTCQB:CBDS) reports revenues of $459,786 for Q3, and $1,674,021 for the nine months ended September 30, 2020, up 137% compared to the nine months ended September 30, 2019. “We are pleased to report strong numbers during this pandemic as our telemedicine portal PrestoDoctor (https://prestodoctor.com) helps patients in California, Nevada, New York, Oklahoma, Missouri, Pennsylvania and Illinois seeking medical cannabis recommendations in the safest way” said President David Tobias. “There has been a broadened acceptance of telehealth due to the Corona virus.” The Company is currently exploring expansion opportunities in additional states, including Ohio, Virginia, and Massachusetts.PrestoDoctor’s expanded market area and heightened advertising have been driving an increase in patient visits to our online platform and a general expansion in consumer awareness of the PrestoDoctor brand. PrestoDoctor reported $1,602,599 revenues in those nine months ended September 30, 2020.GK Manufacturing and Packaging subsidiary was in the start-up phase for the nine months ended September 30, 2020. Revenue and operating efficiencies were impacted by the pandemic, as was the learning curve required for the labor force to become familiar with the manufacturing equipment, the cost of moving into a new facility, and the need to build a backlog of customer orders to streamline the production process. The start-up phase has taken longer than expected, primarily due to the pandemic, however management expects these negative factors to lessen in the coming periods and is currently focused on building its customer base and product line. “The CBD product market in the U. S. is estimated at over $1.7 Billion in 2020, and GK Manufacturing & Packaging, as a CBD product formulator, contract manufacturer, and fulfillment center is poised to gain greater market share in 2021 as celebrity brands and start-up brands needing our services continue to emerge", Tobias stated.About PrestoDoctor PrestoDoctor is rated the 1 online medical marijuana doctor by tens of thousands of medical cannabis patients who have received fully qualified medical marijuana recommendations. PrestoDoctor is the only service to offer patients a custom treatment plan after they have a confidential evaluation with a licensed, highly knowledgeable physician who is an expert in treatment methods, dosing levels, and cannabis products. Founded in 2015, PrestoDoctor services are available in legal medical marijuana states: California, Missouri, New York, Nevada, Oklahoma, Pennsylvania, and Illinois. A HIPAA and HITECH compliant telemedicine company, PrestoDoctor is a member of the American Telemedicine Association (ATA), maintaining the highest customer satisfaction rating for any telemedicine service online with over 14,000 5-star reviews www.prestodoctor.comAbout GK Manufacturing & Packaging: GK Manufacturing (http://gkmanufacturinginc.com) is a Southern California based contract manufacturing, co-packing and white label company, producing a wide range of highest quality, lab-tested CBD products including edibles, tinctures, drinks and topicals. GK specializes in short batch runs, formulation, mixology, graphics/labeling and fulfillment. In-house brands include the well-established Ganja Juice brand, Canna Science,and Murray & Roccos CBD infused pet line. Shop their new portal at (https://cbdinit.com).Cannabis Sativa, Inc. (CBDS) is engaged in telehealth, contract manufacturing CBD infused products, and the licensing of cannabis related intellectual property, marketing and branding for cannabis based products and services, operation of cannabis related technology services, and ancillary business activities. CBDS holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge; a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery and trade secret formulas and processes, and operates subsidiaries including: PrestoDoctor® (https://prestodoctor.com), GK Manufacturing & Packaging (http://gkmanufacturinginc.com), Wild Earth Naturals® (https://wildearthnaturals.com), and iBudtender (https://ibudtender.com). The Company licenses the hi and White Rabbit brands, and is the official licensee for Virgin Mary Jane Brand (https://virginmaryjanebrand.com).Forward Looking Statements: This press release contains forward-looking statements. Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company’s success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Contact Information: (702) 762-3123 https://www.cannabissativa.com

  • PrestoDoctor Co-Founder Rob Tankson to Speak at “Bridging the Gap” Medical Cannabis Conference
    GlobeNewswire

    PrestoDoctor Co-Founder Rob Tankson to Speak at “Bridging the Gap” Medical Cannabis Conference

    MEDICAL CANNABIS CONFERENCE 2020 Bridging the GapMesquite, NV, Oct. 13, 2020 (GLOBE NEWSWIRE) -- MESQUITE, NV/ October 13, 2020 / Cannabis Sativa, Inc. (OTCQB: CBDS) proudly announces that Rob Tankson, COO and co-founder of PrestoDoctor will be a featured speaker at The Medical Cannabis Conference 2020 at the University of Toronto Scarborough on October 13, 2020. Bridging the Gap: Exploring Potential Links Between Academia and the Medical Cannabis Industry features leading experts in business and academia discussing pressing issues impacting the global industry.  “PrestoDoctor made a strategic decision to educate our patients about cannabis products, usage methods, and more,” COO Tankson said. “Scientific research documenting and exploring the benefits of cannabis is essential to bridge the gap between helping society and using cannabis as a medicine.  I’m pleased to be chosen to speak to such a luminary crowd about our experience”. Mr Tankson is scheduled to present on Tuesday, October 13, 2020 9:10–10:00 am ET  Kick-off Panel: Connecting Academia with Industry 3:15–4:00 pm ET Mergers and Acquisitions in the Global Cannabis Industry About PrestoDoctor PrestoDoctor is rated the 1 online medical marijuana doctor by tens of thousands of medical cannabis patients who have received fully qualified medical marijuana recommendations. PrestoDoctor is the only service to offer patients a custom treatment plan after they have a confidential evaluation with a licensed, highly knowledgeable physician who is an expert in treatment methods, dosing levels, and cannabis products. Founded in 2015, PrestoDoctor services are available in legal medical marijuana states: California, Missouri, New York, Nevada, Oklahoma, Pennsylvania, and Illinois. A HIPAA and HITECH compliant telemedicine company, PrestoDoctor is a member of the American Telemedicine Association (ATA), maintaining the highest customer satisfaction rating for any telemedicine service online with over 14,000 5-star reviews www.prestodoctor.com About GK Manufacturing & Packaging: GK Manufacturing is a Southern California based contract manufacturing, co-packing, and white label company, producing a wide range of highest quality, lab-tested CBD products including edibles, tinctures, drinks and topicals. GK specializes in short batch runs, formulation, mixology, graphics/labeling, and fulfillment. In–house brands include the well-established Ganja Juice brand (http://ganja-juice.com),Canna Science, and Murray & Rocco’s CBD infused pet line. About Cannabis Sativa, Inc.: Cannabis Sativa, Inc. (“CBDS”) is engaged in telehealth, contract manufacturing CBD infused products, and the licensing of cannabis-related intellectual property, marketing and branding for cannabis-based products and services, operation of cannabis-related technology services, and ancillary business activities. CBDS holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge; a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery and trade secret formulas and processes, and operates subsidiaries including: PrestoDoctor® (https://prestodoctor.com), GK Manufacturing & Packaging (http://gkmanufacturinginc.com), Wild Earth Naturals® (https://wildearthnaturals.com), and iBudtender (https://ibudtender.com). The Company licenses the “hi” and “White Rabbit” brands and is the official licensee for Virgin Mary Jane Brand (https://virginmaryjanebrand.com). Forward-Looking Statements: This press release contains “forward-looking statements.” Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company’s success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Contact Information: (702) 762-3123 https://www.cannabissativa.comAttachment * MEDICAL CANNABIS CONFERENCE 2020 CONTACT: (702) 762-3123 https://cannabissativainc.com

  • Cannabis Sativa Allowed HI Mark by USPTO as Pending
    GlobeNewswire

    Cannabis Sativa Allowed HI Mark by USPTO as Pending

    hi shirts w forbes quote Bet a lot of other pot startups will be wishing they grabbed that branding first girl walking in hi tshirt GET HIMesquite, NV, Aug. 27, 2020 (GLOBE NEWSWIRE) -- MESQUITE, NV / August 27, 2020 / Cannabis Sativa, Inc. (OTCQB: CBDS) announces that the US Patent and Trademark Office has allowed pending the “HI” Trademark, US Trademark Application Number 86550730 on August 18, 2020. “We are pleased to culminate what has been a tenuous application process for an important brand which had been objected to by a major Canadian cannabis company and has since been settled” said CEO David Tobias.” Federal trademark protection for marijuana products has been and still is unavailable because cannabis can’t be lawfully sold across state lines. “A decision was made by management to file for brand protection under the apparel category until change occurs”, CEO Tobias stated. Shoppers can visit our online store at https://wildearthnaturals.com/collections/all.About PrestoDoctorPrestoDoctor is rated the 1 online medical marijuana doctor by tens of thousands of medical cannabis patients who have received fully qualified medical marijuana recommendations. PrestoDoctor is the only service to offer patients a custom treatment plan after they have a confidential evaluation with a licensed, highly knowledgeable physician who is an expert in treatment methods, dosing levels, and cannabis products. Founded in 2015, PrestoDoctor services are available in legal medical marijuana states: California, Missouri, New York, Nevada, Oklahoma, Pennsylvania, and Illinois. A HIPAA and HITECH compliant telemedicine company, PrestoDoctor is a member of the American Telemedicine Association (ATA), maintaining the highest customer satisfaction rating for any telemedicine service online with over 14,000 5-star reviews www.prestodoctor.comAbout GK Manufacturing & Packaging:GK Manufacturing is a Southern California based contract manufacturing, co-packing and white label company, producing a wide range of highest quality, lab-tested CBD products including edibles, tinctures, drinks and topicals. GK specializes in short batch runs, formulation, mixology, graphics/labeling and fulfillment. In–house brands include the well-established Ganja Juice brand (http://ganja-juice.com),Canna Science, and Murray & Rocco’s CBD infused pet line.About Cannabis Sativa, Inc.:Cannabis Sativa, Inc. (“CBDS”) is engaged in telehealth, contract manufacturing CBD infused products, and the licensing of cannabis related intellectual property, marketing and branding for cannabis based products and services, operation of cannabis related technology services, and ancillary business activities. CBDS holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge; a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery and trade secret formulas and processes, and operates subsidiaries including: PrestoDoctor® (https://prestodoctor.com), GK Manufacturing & Packaging (http://gkmanufacturinginc.com), Wild Earth Naturals® (https://wildearthnaturals.com), and iBudtender (https://ibudtender.com). The Company licenses the “hi” and “White Rabbit” brands, and is the official licensee for Virgin Mary Jane Brand (https://virginmaryjanebrand.com).Forward Looking Statements:This press release contains “forward-looking statements.” Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company’s success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.Contact Information:(702) 762-3123https://www.cannabissativa.comAttachments * hi shirts w forbes quote * girl walking in hi tshirt